SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syschem (India) - Quaterly Results

27 Jul 2022 Evaluate
The sales for the June 2022 quarter moved down to Rs. 163.58 millions as compared to Rs. 195.53 millions during the year-ago period.The Total Profit for the quarter ended June 2022 of Rs. 7.09 millions grew from Rs.-14.89 millions Operating profit Margin for the quarter ended June 2022 improved to 13.99% as compared to -8.61% of corresponding quarter ended June 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 163.58 195.53 -16.34 163.58 195.53 -16.34 656.33 744.15 -11.80
Other Income 0.51 0.02 2450.00 0.51 0.02 2450.00 1.26 2.56 -50.78
PBIDT 13.99 -8.61 -262.49 13.99 -8.61 -262.49 6.93 -49.04 -114.13
Interest 0.07 0.08 -12.50 0.07 0.08 -12.50 2.84 0.55 416.36
PBDT 13.92 -8.69 -260.18 13.92 -8.69 -260.18 4.09 -49.59 -108.25
Depreciation 6.83 6.20 10.16 6.83 6.20 10.16 25.81 23.55 9.60
PBT 7.09 -14.89 -147.62 7.09 -14.89 -147.62 -21.72 -73.14 -70.30
TAX 0.00 0.00 0.00 0.00 0.00 0.00 -4.66 -17.49 -73.36
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -4.66 -17.49 -73.36
PAT 7.09 -14.89 -147.62 7.09 -14.89 -147.62 -17.06 -55.65 -69.34
Equity 305.40 215.40 41.78 305.40 215.40 41.78 232.90 215.40 8.12
PBIDTM(%) 8.55 -4.40 -294.22 8.55 -4.40 -294.22 1.06 -6.59 -116.02

Syschem (India) Share Price

51.69 1.31 (2.60%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×